A carregar...
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure
AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/ https://ncbi.nlm.nih.gov/pubmed/25892862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|